Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetyl Glucosamine for IBS-D
NCT02504060Phase 3Unknown
- Sponsor
- Army Medical University
- Start
- Jun 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of n-acetyl-d-glucosamine in Irritable bowel syndrome with diarrhea (IBS-D) (2 arms), sponsored by Army Medical University. Primary endpoints: Abdominal Pain Intensity at 1.5 years and Stool Consistency at 1.5 years. Status: unknown.
02
Drugs
n-acetyl-d-glucosamine
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT02504060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02504060.